BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8008626)

  • 1. The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group.
    Wieczorek Z; Zimecki M; Słoń JJ; Siemion IZ
    Peptides; 1994; 15(2):215-21. PubMed ID: 8008626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Lys-residue deletion on the immunomodulatory activity of peptides related to immunosuppressive region of lactoferrin.
    Słoń JI; Siemion IZ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):211-6. PubMed ID: 8744698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
    Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of endogenous xenotropic murine retrovirus by treatment with the tetrapeptides, tuftsin and kentsin.
    Suk WA; Long CW
    J Gen Virol; 1981 Jan; 52(Pt 1):189-94. PubMed ID: 6167663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
    Paradowski A; Dynowski Z; Kubik A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further investigations on the antinociceptive activity of tuftsin analogs.
    Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the effect of tuftsin and its analogs on immunogenesis].
    Val'dman AV; Ratnikov VI; Makarova NV; Kozlovskaia MM
    Biull Eksp Biol Med; 1982 Dec; 94(12):56-7. PubMed ID: 6897519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
    Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
    J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IL-1 activity of peptide fragments of IL-1 family proteins.
    Siemion IZ; Kluczyk A; Wieczorek Z
    Peptides; 1998; 19(2):373-82. PubMed ID: 9493871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo immunopharmacological properties of tuftsin and four analogs.
    Kraus-Berthier L; Rémond G; Visalli M; Héno D; Portevin B; Vincent M
    Immunopharmacology; 1993; 25(3):261-7. PubMed ID: 8354642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
    Wieczorek Z; Słoń J; Siemion IZ
    Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evidence on the possible interleukin-1 alpha tuftsin competition.
    Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.